AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,430,032 | +337.4% | 33,164 | +196.5% | 0.00% | +100.0% |
| Q1 2024 | $326,908 | +50.4% | 11,184 | +44.9% | 0.00% | – |
| Q2 2023 | $217,311 | -86.4% | 7,717 | -77.7% | 0.00% | -100.0% |
| Q3 2021 | $1,594,000 | +316.2% | 34,531 | +380.6% | 0.00% | +200.0% |
| Q2 2021 | $383,000 | +7.3% | 7,185 | +33.3% | 0.00% | – |
| Q1 2019 | $357,000 | +43.4% | 5,392 | 0.0% | 0.00% | – |
| Q4 2018 | $249,000 | -74.0% | 5,392 | -56.5% | 0.00% | -100.0% |
| Q3 2018 | $957,000 | -11.3% | 12,409 | -3.1% | 0.00% | 0.0% |
| Q2 2018 | $1,079,000 | +57.1% | 12,811 | +8.9% | 0.00% | 0.0% |
| Q1 2017 | $687,000 | -86.6% | 11,764 | -90.5% | 0.00% | -85.7% |
| Q4 2016 | $5,145,000 | -26.9% | 123,303 | -7.5% | 0.01% | -36.4% |
| Q3 2016 | $7,041,000 | +376.1% | 133,306 | +277.6% | 0.01% | +266.7% |
| Q2 2016 | $1,479,000 | +11.4% | 35,308 | +72.6% | 0.00% | +50.0% |
| Q4 2015 | $1,328,000 | -20.0% | 20,454 | -13.1% | 0.00% | -33.3% |
| Q3 2015 | $1,661,000 | -67.0% | 23,527 | -48.0% | 0.00% | -70.0% |
| Q2 2015 | $5,030,000 | +40.0% | 45,261 | +18.8% | 0.01% | +25.0% |
| Q1 2015 | $3,592,000 | +1085.5% | 38,100 | +1311.1% | 0.01% | +700.0% |
| Q4 2014 | $303,000 | -64.7% | 2,700 | -80.7% | 0.00% | -50.0% |
| Q3 2014 | $859,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 514,711 | $22,194,338 | 5.19% |
| ACUTA CAPITAL PARTNERS, LLC | 78,700 | $3,393,544 | 2.86% |
| Bellevue Group AG | 3,879,548 | $167,286,110 | 2.72% |
| Parkman Healthcare Partners LLC | 446,416 | $19,249,458 | 2.58% |
| Eagle Health Investments LP | 330,830 | $14,265,390 | 2.50% |
| SECTOR GAMMA AS | 121,844 | $5,253,913 | 1.96% |
| Frazier Life Sciences Management, L.P. | 871,974 | $37,599,519 | 1.76% |
| BVF INC/IL | 1,190,107 | $51,317,414 | 1.44% |
| Rock Springs Capital Management LP | 1,044,261 | $45,028,534 | 1.36% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,654,502 | $243,822,126 | 1.15% |